Liquidia Technologies Inc (LQDA) experienced a pre-market plunge of 7.62% on Thursday, as investors reacted negatively to the company's latest earnings report.
The biopharmaceutical company reported fourth-quarter earnings per share of $0.15, which missed the FactSet consensus estimate of $0.18. For the full year 2025, Liquidia reported an EPS loss of $0.80, falling short of the IBES estimate of a $0.76 loss.
Despite reporting quarterly sales of $92.021 million that beat analyst expectations of $83.634 million, the earnings miss combined with a significant 93% increase in selling, general and administrative expenses to $157.2 million for the full year appears to have driven the negative market reaction in pre-market trading.
Comments